Regulation - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

126 to 150 of 247 results

New Zealand decision to fund unapproved medicines for various conditions

07-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, has announced the approval of an agreement with…

Asia-PacificFinancialGenericsRegulation

Taiho Pharma files for approval of cancer drug TAS-102 in Japan

27-02-2013

Japanese drugmaker Taiho Pharmaceutical, a subsidiary of Otsuka (TYO: 4768) says that it submitted an…

Asia-PacificOncologyOtsukaPharmaceuticalRegulationTaiho PharmaceuticalTAS-102

Japanese approval for Actelion's epoprostenol "ACT"

19-02-2013

Europe's largest biotech firm Actelion (SIX: ATLN) yesterday announced that Japan's Ministry of Health,…

ActelionAsia-PacificBiotechnologyepoprostenol "ACT"RegulationRespiratory and PulmonaryVeletri

Takeda called on to take corrective action over Alinamin-F5 marketing and manufacturing

15-02-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) revealed it has received an Order for Corrective…

Alinamin-F5Asia-PacificPharmaceuticalProductionRegulationTakeda Pharmaceuticals

Celgene's Revlimid approved in China for MM; gets PDUFA date in USA for mantle cell lymphoma

12-02-2013

Celgene Corp's (Nasdaq: CELG) European subsidiary revealed that Revlimid (lenalidomide) has been granted…

Asia-PacificBiotechnologyCelgeneNorth AmericaOncologyRegulationRevlimid

EMA and European Commission renew confidentiality arrangement with Japan

07-02-2013

The European Medicines Agency and the European Commission's Directorate General for Health and Consumers…

Asia-PacificBiotechnologyEuropePharmaceuticalRegulation

New Zealand takes significant step towards national hospital medicines list

05-02-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, has taken a further major step towards forming…

Asia-PacificHealthcarePharmaceuticalPoliticsRegulation

New Zealand considers listing Merck & Co's Bridion

30-01-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list the…

Asia-PacificBridionFinancialMerck & CoNeurologicalPharmaceuticalRegulation

Kyowa Hakko set to file for pegfilgrastim approval in Japan following strong Ph III data

28-01-2013

Mid-size Japanese drugmaker Kyowa Hakko Kirin (TYO: 4151) on Friday released positive top-line results…

Asia-PacificBiotechnologyKyowa Hakko KirinOncologypegfilgrastimPharmaceuticalRegulationResearch

China gains WHO designation for biological products center

20-01-2013

China's Institute for Biological Product Control (IBPC) of the National Institutes for Food and Drug…

Asia-PacificBiotechnologyRegulationVaccines

Bayer files for Japanese approval of Eylea for macular edema following CRVO

07-01-2013

German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry…

afliberceptAsia-PacificBayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationSanten Pharmaceuticals

Australian review finds more work needed on new anticoagulants

19-12-2012

A report into anticoagulation therapies released yesterday by Australian Minister for Health Tanya Plibersek…

Asia-PacificBoehringer IngelheimCardio-vascularPharmaceuticalPradaxaPricingRegulation

Japan Tobacco files for Japanese approval of elvitegravir

11-12-2012

Japan Tobacco (TSE:2914) has filed a New Drug Application for marketing approval of a novel anti-HIV…

Anti-viralsAsia-PacificBiotechnologyelvitegravirGilead SciencesJapan TobaccoPharmaceuticalRegulationTorii Pharma

New Zealand's PHARMAC lifts restrictions on some cancer drugs

09-12-2012

New Zealand's Pharmaceutical Management Agency PHARMAC has removed the Special Authority funding requirements…

Asia-PacificOncologyPharmaceuticalRegulation

Trans Tasman joint therapeutic products scheme progresses

06-12-2012

Progress towards a joint Australia and New Zealand therapeutic products regulatory scheme continued with…

Asia-PacificBiotechnologyPharmaceuticalRegulation

Covance gains SFDA GLP Certification for its Shanghai facility; TOT opens new Suzhou plant

05-12-2012

USA-based contract research organization (CRO) Covance (NYSE: CVD) says that its early development facility…

Asia-PacificCovancePharmaceuticalProductionRegulationResearchTOT Biopharm

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

03-12-2012

Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

New Zealand to fund Gilead's Atripla and Truvada

27-11-2012

New Zealand's Pharmaceutical Management Agency PHARMAC says that, effective December 1, it will fund…

Anti-viralsAsia-PacificAtriplaBiotechnologyFinancialGilead SciencesPharmaceuticalRegulationTruvada

126 to 150 of 247 results

Back to top